FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback